Evidence map›Paper›PMID 34830546›Full record

ArticleJournal of clinical medicine2021

Predictors of Ascending Aorta Enlargement and Valvular Dysfunction Progression in Patients with Bicuspid Aortic Valve.

Angela Lopez, Ilaria Dentamaro, Laura Galian, Francisco Calvo, Josep M Alegret, Violeta Sanchez, Rodolfo Citro, Antonella Moreo, Fabio Chirillo, Paolo Colonna and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Progression of stenosis severity and aortopathy in adult patients with congenital aortic stenosis.International journal of cardiology. Congenital heart disease · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Angela LopezDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.ORCID 0000-0001-7433-2137
Ilaria DentamaroDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.
Laura GalianDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.
Francisco CalvoCardiology Department, Hospital Alvaro Cunqueiro, 36213 Vigo, Spain.ORCID 0000-0002-3235-3658
Josep M AlegretCardiology Department, Hospital Universitari Sant Joan de Reus, IISPV, Universitat Rovira i Virgili, 43204 Reus, Spain.ORCID 0000-0002-6117-5512
Violeta SanchezCardiology Department, University Hospital 12 de Octubre, 28041 Madrid, Spain.
Rodolfo CitroCardiology Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", 84125 Salerno, Italy.
Antonella MoreoCardiology Department, Niguarda Ca' Granda Hospital, 20162 Milan, Italy.ORCID 0000-0003-3150-3885
Fabio ChirilloCardiology Department, Bassano del Grappa General Hospital, 36061 Bassano Del Grappa, Italy.
Paolo ColonnaCardiology Department, Polyclinic Hospital of Bari, 70124 Bari, Italy.ORCID 0000-0001-5864-2012
María Celeste CarreroInstituto Cardiovascular San Isidro, Sanatorio Las Lomas, Buenos Aires 3031, Argentina.
Eduardo BossoneCardiology Department, Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, 80131 Napoli, Italy.ORCID 0000-0003-2769-9950
Sergio MoralServei de Cardiologia, Hospital Josep Trueta, 17007 Girona, Spain.ORCID 0000-0003-0082-0597
Augusto Sao-AvilesDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.
Laura GutiérrezDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.
Gisela Teixido-TuraDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.
Jose Rodríguez-PalomaresDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.ORCID 0000-0002-7229-9780
Arturo EvangelistaDepartment of Cardiology, University Hospital Vall d'Hebron, CIBERCV, 08035 Barcelona, Spain.
Centro de Investigación en Red en Enfermedades Cardiovasculares · ESAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITHospital Quirón Teknon · ESHospital Universitari de Girona Doctor Josep Trueta · ESInstitut de Recerca Biomèdica Catalunya Sud · ESInstituto Cardiovascular de Buenos Aires · AROspedale San Bassiano · ITOspedali Riuniti San Giovanni di Dio e Ruggi d'Aragona · ITResearch Institute Hospital 12 de Octubre · ESUniversity Hospital Complex Of Vigo · ESUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bicuspid aortic valve (BAV) patients are at high risk of developing progressive aortic valve dysfunction and ascending aorta dilation. However, the progression of the disease is not well defined. We aimed to assess mid-long-term aorta dilation and valve dysfunction progression and their predictors. Patients were referred from cardiac outpatient clinics to the echocardiographic laboratories of 10 tertiary hospitals and followed clinically and by echocardiography for >5 years. Seven hundred and eighteen patients with BAV (median age 47.8 years [IQR 33-62], 69.2% male) were recruited. BAV without raphe was observed in 11.3%. After a median follow-up of 7.2 years [IQR5-8], mean aortic root growth rate was 0.23 ± 0.15 mm/year. On multivariate analysis, rapid aortic root dilation (>0.35 mm/year) was associated with male sex, hypertension, presence of raphe and aortic regurgitation. Annual ascending aorta growth rate was 0.43 ± 0.32 mm/year. Rapid ascending aorta dilation was related only to hypertension. Variables associated with aortic stenosis and regurgitation progression, adjusted by follow-up time, were presence of raphe, hypertension and dyslipidemia and basal valvular dysfunction, respectively. Intrinsic BAV characteristics and cardiovascular risk factors were associated with aorta dilation and valvular dysfunction progression, taking into account the inherent limitations of our study-design. Strict and early control of cardiovascular risk factors is mandatory in BAV patients.

Indexed as

aneurysmaortic regurgitationaortic stenosisbicuspid aortic valve

Identifiers

PMID34830546
PMCPMC8621265
OpenAlexW3214156095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.